Preventing heavy bleeding after C-section with a care bundle
Part of Women’s health & pregnancy clinical trials.
This trial tests if a set of medical steps (a care bundle) can reduce heavy bleeding after cesarean delivery. You might be eligible if you're having a C-section at a participating hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a cesarean delivery (C-section)
- You receive care at a public hospital that does more than 100 C-sections a year
- You agree to take part and sign a consent form
- You have a blood test (complete blood count) within 2 weeks before your surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for women having their second or third planned c-section. It tests if giving a medicine called tranexamic acid helps prevent heavy bleeding. The medicine is safe and commonly used to reduce bleeding.
This study tests a new device called U-CaVIT to prevent heavy bleeding after a planned cesarean delivery in women at high risk. It compares the U-CaVIT device to standard care to see which works better.
This trial tests a new method to prevent heavy bleeding during cesarean sections. It may help make the procedure safer for mothers.
This trial tests whether giving a specific combination of three medicines during a planned c-section is better than one medicine alone for preventing postpartum hemorrhage (heavy bleeding after birth).
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
Hear when a new Cesarean Delivery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.